TRIB (Trinity Biotech plc) Stock Analysis - Analyst Ratings

Trinity Biotech plc (TRIB) is a publicly traded Healthcare sector company. As of May 21, 2026, TRIB trades at $0.59 with a market cap of $11.54M and a P/E ratio of 0.00. TRIB moved +6.65% today. Year to date, TRIB is -20.85%; over the trailing twelve months it is -25.11%. Its 52-week range spans $0.48 to $3.44. Rallies surfaces TRIB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate TRIB?

The average price target is $0.00.

TRIB Key Metrics

Key financial metrics for TRIB
MetricValue
Price$0.59
Market Cap$11.54M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.22%
52-Week High$3.44
52-Week Low$0.48
Volume170
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

TRIB Analyst Consensus

TRIB analyst coverage data. Average price target: $0.00.

Latest TRIB News

Recent TRIB Insider Trades

  • ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 17.80K (~$924.52K) on Feb 18, 2004.
  • ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 92.00K (~$4.82M) on Feb 17, 2004.
  • ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 65.20K (~$3.39M) on Feb 13, 2004.

Common questions about TRIB

What do analysts rate TRIB?
The average price target is $0.00.
Does Rallies show TRIB price targets?
Yes. Rallies tracks TRIB analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is TRIB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TRIB. It does not provide personalized investment advice.
TRIB

TRIB